Rocket Pharmaceuticals Inc (RCKT)

SG&A Expenses

$67.52M

TTM · Period ending: · USD

RCKT logo

RCKT SG&A Expenses

Latest reported$67.52M
RCKT SG&A Expenses ($2.31M → $67.52M)
High-resolution chart · PNG

RCKT sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Rocket Pharmaceuticals Inc SG&A Expenses — Annual fiscal periods (USD)
Period endingSG&A Expenses (USD)
86,501,000
101,961,000
73,317,000
58,773,000
41,772,000
27,921,000
17,528,000
17,886,000
12,544,000
9,894,000
7,842,000
2,112,000
1,324,000
2,307,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.